Nancy A. Simonian, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 134,713 shares at $0.27 ($36K) on 2024-11-25, disclosed to the SEC on 2024-11-27.
Open-market sale of $36k SYRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MLNM | SELL | 2008-03-07 | $234K | — | Filing → |
| MLNM | SELL | 2008-03-04 | $69K | — | Filing → |
| MLNM | SELL | 2007-12-14 | $1.7M | — | Filing → |